Avita Medical, Inc. - Common Stock — Rendiconto Finanziario (NASDAQ:RCEL)

Avita Medical, Inc. - Common Stock

Avita Medical is a clinical and commercial company developing and marketing a range regenerative medicine products. The first regenerative medicine product brought to the market by Avita Medical was ReCell spray-on skin for the treatment of burns. The two latest products are ReNovaCell, for Aesthetics and Plastic applications including skin trauma, and ReGenerCell for the treatment of chronic wounds. The Avita Medical regenerative product range is currently marketed in Europe, the Middle East, Africa and Australia.

RCEL

Financials

Avita Medical, Inc. - Common Stock

Notizie

AVITA Medical, Inc. (RCEL) Discusses Business Progress, Operational Changes and Sequential Revenue Growth Transcript

Gli EPS di Avita Medical hanno mancato le aspettative per 0,06$, il fatturato supera le previsioni

AVITA Medical nomina Cary Vance amministratore delegato permanente

AVITA Medical ottiene l’autorizzazione per RECELL GO in Australia

AVITA Medical, Inc. (RCEL) Shareholder/Analyst Call Transcript

Avita Medical (RCEL) Soars 14.1%: Is Further Upside Left in the Stock?

AVITA Medical: Why The BARDA Rally Changes Nothing (NASDAQ:RCEL)

AVITA Medical ottiene contratto BARDA da 25,5 mln $ per emergenze ustioni

Avita Medical alla conferenza TD Cowen: crescita e focus strategico

Avita Medical at TD Cowen Conference: Growth and Strategic Focus

Wall Street Analysts Believe Avita Medical (RCEL) Could Rally 29.87%: Here's is How to Trade

Avita Medical (RCEL) Upgraded to Buy: Here's What You Should Know